Latest AdAlta (ASX:1AD) News
Page 4
Page 4 of 6
AdAlta Moves Manufacturing of CAR-T Therapy to Australia After Rare Tumour Clearance
29 Apr 2026
Healthcare Wrap - Week 17 (20 Apr -> 24 Apr) 2026
25 Apr 2026
AdAlta and Partners Target Cell Therapy Scale-Up with Automated IRO Platform
21 Apr 2026
Healthcare Wrap - Week 14 (30 Mar -> 3 Apr) 2026
4 Apr 2026
AdAlta’s CAR-T Therapy Delivers Rare Tumour Disappearances in Mesothelioma Trial
1 Apr 2026
Healthcare Wrap - Week 13 (23 Mar -> 27 Mar) 2026
28 Mar 2026
AdAlta Accelerates CAR-T Therapy Development with Shanghai Cell Therapy Group
27 Mar 2026
Healthcare Wrap - Week 12 (16 Mar -> 20 Mar) 2026
21 Mar 2026
AdAlta Secures Canadian Patent, Cementing AD-214’s Global Protection
20 Mar 2026
Healthcare Wrap - Week 8 (16 Feb -> 20 Feb) 2026
21 Feb 2026
AdAlta Advances CAR-T Collaboration and Boosts Capital Amid $2.44M Half-Year Loss
20 Feb 2026
Healthcare Wrap - Week 5 (26 Jan -> 30 Jan) 2026
31 Jan 2026